{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:29Z","timestamp":1791520949244,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009594","name":"University of P\u00e9cs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009594","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Annual flu vaccination is recommended for children with rheumatic diseases. We investigated the cellular and humoral immune response and safety in pediatric patients that received inactivated influenza vaccines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a comparative study of in 41 children with juvenile idiopathic arthritis (JIA) receiving influenza vaccination while being treated with methotrexate (MTX) or biological therapy. The influenza vaccination was administered as a single dose of trivalent influenza vaccine (TIV). Serological tests to monitor seroconversion and seroprotection were performed at baseline and at 4 as well as 12 weeks after vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In all of the 41 children with JIA and the 22 healthy children seroconversion and seroprotection were observed for Influenza A. For Influenza B, no adequate seroconversion rates were not detected in any of the groups studied. No significant differences were observed in lymphocyte subpopulations when analysing time points and groups simultaneously. There were no relapses or cases of influenza infection after the vaccination. Our findings do not suggest non-specific immune activation following vaccination based on the distribution and quantity of the lymphocyte subsets that were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present study demonstrates adequate seroprotection rates against influenza A in immunosuppressed children with JIA. The trivalent vaccine had good immunogenicity and was safe to use in both JIA treatment groups.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12969-025-01099-y","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T07:16:14Z","timestamp":1745565374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Influenza vaccination in patients with juvenile idiopathic arthritis under different treatments: safety and immune response"],"prefix":"10.1186","volume":"23","author":[{"given":"Adam","family":"Gyori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Ottoffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Decsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Berki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timea","family":"Dergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"Mosdosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"1","key":"1099_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12969-019-0305-x","volume":"17","author":"A Nagy","year":"2019","unstructured":"Nagy A, M\u00e1trai P, Hegyi P, Alizadeh H, Bajor J, Czopf L, et al. The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis. Pediatr Rheumatol Online J. 2019;17(1):4.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"1099_CR2","doi-asserted-by":"publisher","first-page":"e20163690","DOI":"10.1542\/peds.2016-3690","volume":"139","author":"TR Shope","year":"2017","unstructured":"Shope TR, Walker BH, Aird LD, Southward L, McCown JS, Martin JM. Pandemic influenza preparedness among child care center directors in 2008 and 2016. Pediatrics. 2017;139(6):e20163690.","journal-title":"Pediatrics"},{"key":"1099_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/1471-2458-12-968","volume":"12","author":"EN Antonova","year":"2012","unstructured":"Antonova EN, Rycroft CE, Ambrose CS, Heikkinen T, Principi N. Burden of pediatric influenza in Western Europe: A systematic review. BMC Public Health. 2012;12:968.","journal-title":"BMC Public Health"},{"issue":"9","key":"1099_CR4","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1080\/21645515.2017.1345400","volume":"13","author":"S Yan","year":"2017","unstructured":"Yan S, Weycker D, Sokolowski S. US healthcare costs attributable to type A and type B influenza. Hum Vaccin Immunother. 2017;13(9):2041\u20137.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"1099_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/irv.12522","volume":"12","author":"L Jennings","year":"2018","unstructured":"Jennings L, Huang QS, Barr I, Lee PI, Kim WJ, Buchy P, et al. Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region. Influenza Other Respir Viruses. 2018;12(3):383\u2013411.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10095","key":"1099_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules C, Subbarao K, Influenza. Lancet. 2017;390(10095):697\u2013708.","journal-title":"Lancet"},{"key":"1099_CR7","doi-asserted-by":"publisher","first-page":"744774","DOI":"10.3389\/fimmu.2021.744774","volume":"6","author":"A Bansal","year":"2021","unstructured":"Bansal A, Trieu MC, Mohn KGI, Cox RJ, Safety. Immunogenicity, efficacy and effectiveness of inactivated influenza vaccines in healthy pregnant women and children under 5 years: an Evidence-Based clinical review. Front Immunol. 2021;6:12:744774. https:\/\/doi.org\/10.3389\/fimmu.2021.744774.","journal-title":"Front Immunol"},{"issue":"1","key":"1099_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/annrheumdis-2022-222574","volume":"82","author":"MHA Jansen","year":"2023","unstructured":"Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, et al. EULAR\/PRES recommendations for vaccination of pediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis. 2023;82(1):35\u201347.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1099_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/acr.25045","volume":"75","author":"AR Bass","year":"2023","unstructured":"Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2023;75(3):449\u201364.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"1099_CR10","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/CVI.00309-12","volume":"19","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Ueno K, Yachie A. Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving Tocilizumab. Clin Vaccine Immunol. 2012;19(10):1700\u20132.","journal-title":"Clin Vaccine Immunol"},{"key":"1099_CR11","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1016\/j.vaccine.2010.06.060","volume":"28","author":"CE Oh","year":"2010","unstructured":"Oh CE, Lee J, Kang JH, Hong YJ, Kim YK, Cheong HJ, et al. Safety and immunogenicity of an inactivated split-virus influenza A\/H1N1 vaccine in healthy children from 6 months to <\u200918 years of age: a prospective, open-label, multi-center trial. Vaccine. 2010;28:5857\u201363.","journal-title":"Vaccine"},{"key":"1099_CR12","first-page":"272","volume":"34","author":"JL Kaine","year":"2007","unstructured":"Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and Pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol. 2007;34:272\u20139.","journal-title":"J Rheumatol"},{"key":"1099_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","volume":"46","author":"MC Kapetanovic","year":"2007","unstructured":"Kapetanovic MC, Saxne T, Nilsson JA, et al. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford). 2007;46:608\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"1099_CR14","doi-asserted-by":"crossref","unstructured":"Aikawa NE et al. 2012. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J. Rheumatol. 2012;39:167\u2013173.","DOI":"10.3899\/jrheum.110721"},{"key":"1099_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/ard.2007.077552","volume":"67","author":"LB Gelinck","year":"2008","unstructured":"Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008;67:713\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1099_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2005.036434","volume":"65","author":"I Fomin","year":"2006","unstructured":"Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis. 2006;65:191\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1099_CR17","doi-asserted-by":"publisher","unstructured":"Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Arthritis Rheumatol. 2022;74(4):570\u2013585. https:\/\/doi.org\/10.1002\/art.42036","DOI":"10.1002\/art.42036"},{"issue":"2","key":"1099_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clim.2009.09.014","volume":"134","author":"S Salemi","year":"2010","unstructured":"Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, et al. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol. 2010;134(2):113\u201320.","journal-title":"Clin Immunol"},{"issue":"6","key":"1099_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10165-012-0595-z","volume":"22","author":"T Shinoki","year":"2012","unstructured":"Shinoki T, Hara R, Kaneko U, Miyama T, Imagawa T, Mori M, et al. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving Tocilizumab. Mod Rheumatol. 2012;22(6):871\u20136. https:\/\/doi.org\/10.1007\/s10165-012-0595-z.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"1099_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/INF.0b013e3181f7ce44","volume":"30","author":"C Ogimi","year":"2011","unstructured":"Ogimi C, Tanaka R, Saitoh A, Ohishi T. Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents. Pediatr Infect Dis J. 2011;30(3):208\u201311. https:\/\/doi.org\/10.1097\/INF.0b013e3181f7ce44.","journal-title":"Pediatr Infect Dis J"},{"key":"1099_CR21","first-page":"436","volume":"30","author":"N Toplak","year":"2012","unstructured":"Toplak N, \u0160ubelj V, Kveder3 T, \u010cu\u010dnik S, Prosenc K, Trampu\u0161-Bakija A, et al. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2012;30:436\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1099_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.vaccine.2011.11.083","volume":"30","author":"L Dell\u2019Era","year":"2012","unstructured":"Dell\u2019Era L, Corona F, Daleno C, Scala A, Principi N. Esposito; immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine. 2012;30(5):936\u201340. https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.083.","journal-title":"Vaccine"},{"issue":"1","key":"1099_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12969-017-0190-0","volume":"15","author":"MS Camacho-Lovillo","year":"2017","unstructured":"Camacho-Lovillo MS, Bulnes-Ramos A, Goycochea-Valdivia W, Fern\u00e1ndez-Silveira L, N\u00fa\u00f1ez-Cuadros E, Neth O, et al. Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay. Pediatr Rheumatol Online J. 2017;15(1):62. https:\/\/doi.org\/10.1186\/s12969-017-0190-0.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1099_CR24","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1177\/0961203313505926","volume":"22","author":"NE Aikawa","year":"2013","unstructured":"Aikawa NE, Trudes G, Campos LMA, Pereira RMR, Moraes JCB, Ribeiro AC, et al. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1\/2009 vaccine in young autoimmune rheumatic diseases patients. Lupus. 2013;22:1394\u20138.","journal-title":"Lupus"},{"key":"1099_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/03009742.2012.709272","volume":"42","author":"NE Aikawa","year":"2013","unstructured":"Aikawa NE, Campos LMA, Goldenstein-Schainberg C, Saad CGS, Ribeiro AC, Bueno C, et al. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scand J Rheumatol. 2013;42:34\u201340.","journal-title":"Scand J Rheumatol"},{"key":"1099_CR26","doi-asserted-by":"publisher","unstructured":"Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol. 2011; 216\u2013\u200924. https:\/\/doi.org\/10.1038\/icb.2010.78","DOI":"10.1038\/icb.2010.78"},{"issue":"6","key":"1099_CR27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/annrheumdis-2011-201270","volume":"72","author":"GF Salinas","year":"2013","unstructured":"Salinas GF, De Rycke L, Barendregt B, Paramarta JE, Hreggvidstdottir H, Cantaert T, et al. Anti-TNF treatment blocks the induction of T Cell-Dependent humoral responses. Ann Rheum Dis. 2013;72(6):1037\u201343.","journal-title":"Ann Rheum Dis"},{"key":"1099_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1099_CR29","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1186\/ar3542","volume":"13","author":"JJ Kobie","year":"2011","unstructured":"Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, et al. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther. 2011;13(6):R209.","journal-title":"Arthritis Res Ther"},{"key":"1099_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/CCO.0b013e32835b6386","volume":"25","author":"D Menendez","year":"2013","unstructured":"Menendez D, Shatz M, Resnick MA. Interactions between the tumor suppressor p53 and immune responses. Curr Opin Oncol. 2013;25:85\u201392.","journal-title":"Curr Opin Oncol"},{"key":"1099_CR31","doi-asserted-by":"publisher","first-page":"690940","DOI":"10.3389\/fimmu.2021.690940","volume":"12","author":"EA Leibinger","year":"2021","unstructured":"Leibinger EA, Pauler G, Benedek N, Berki T, Jankovics I, McNally R, et al. Baseline CD3\u2009+\u2009CD56+ (NKT-like) cells and the outcome of influenza vaccination in children undergoing chemotherapy. Front Immunol. 2021;12:690940.","journal-title":"Front Immunol"},{"issue":"3","key":"1099_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16(3):145\u201354.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01099-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T07:16:18Z","timestamp":1745565378000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-025-01099-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01099-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the recommendations of the Declaration of Helsinki and the protocol was approved by the Local Ethics Committee (SN: 7387, University of Pecs, Medical School). Written informed consent was obtained from all patient\u2019s legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}